Nuclear Medicine and Biology
Volume 35, Issue 5 , Pages 589-597 , July 2008

Preparation and preliminary studies on 177Lu-labeled hydroxyapatite particles for possible use in the therapy of liver cancer

  • Sudipta Chakraborty

      Affiliations

    • Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai 400085, India
    • ,
  • Tapas Das

      Affiliations

    • Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai 400085, India
    • ,
  • Haladhar D. Sarma

      Affiliations

    • Radiation Biology and Health Sciences Division, Bhabha Atomic Research Centre, Mumbai 400085, India
    • ,
  • Meera Venkatesh

      Affiliations

    • Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai 400085, India
    • ,
  • Sharmila Banerjee

      Affiliations

    • Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai 400085, India
    • Corresponding Author InformationCorresponding author. Tel.: +1 91 22 2559 3910; fax: +91 22 2550 5151.

Received 12 December 2007 ,Revised 5 March 2008 ,Accepted 16 March 2008.

References 

  1. Parkin MD, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001;94:153–156
  2. Lambert B, Bacher K, Defreyne L, Van Vlierberghe H, Jeong JM, Wang RF, et al. 188Re-HDD/lipiodol therapy for hepatocellular carcinoma: an activity escalation study. Eur J Nucl Med Mol Imaging. 2006;33:344–352
  3. Nijsen JFW, van het Schip AD, Hennink WE, Rook DW, van Rijk PP, de Klerk JMH. Advances in nuclear oncology: microspheres for internal radionuclide therapy of liver tumors. Curr Med Chem. 2002;9:73–82
  4. Nijsen JFW, Jonnenberg BA, Woittiez JRW, Rook DW, Swildens-van Woudenberg IA, van Rijk PP, et al. Holmium-166 poly lactic acid microspheres applicable for intra-arterial radionuclide therapy of hepatic malignancies: effects of preparation and neutron activation techniques. Eur J Nucl Med. 1999;26:699–704
  5. Cady B. Natural history of primary and secondary tumors of the liver. Semin Oncl. 1983;10:127–135
  6. Hafeli UO, Casillas S, Dietz DW, Pauer GJ, Rybicki LA, Conzone SD, et al. Hepatic tumor radioembolization in a rat model using radioactive rhenium (186Re/188Re) glass microspheres. Int J Radiat Oncl Biol Phys. 1999;44:189–199
  7. Farmer DG, Basuttil RW. The role of multimodal therapy in the treatment of hepatocellular carcinoma. Cancer. 1994;73:2669–2670
  8. Nijsen F, Rook D, Brandt C, Meijer R, Dullens H, Jonnenberg BA, et al. Targeting of liver tumour in rats by selective delivery of holmium-166 loaded microspheres: a biodistribution study. Eur J Nucl Med. 2001;28:743–749
  9. Meade VM, Burton MA, Gray BN, Self GW. Distribution of different sized microspheres in experimental hepatic tumours. Eur J Cancer Clin Oncl. 1987;23:37–41
  10. Anderson JH, Angerson WJ, Willmott N, Kerr DJ, McArdle CS, Cooke TG. Regional delivery of microspheres to liver metastases: the effect of particle size and concentration on intrahepatic distribution. Br J Cancer. 1991;64:1031–1034
  11. Leung WT, Lau WY, Ho S, Chan M, Leung N, Lin J, et al. Selective internal radiation therapy with intra-arterial iodine-131-lipiodol in inoperable hepatocellular carcinoma. J Nucl Med. 1994;35:1313–1318
  12. Ackerman NB, Lien WM, Kondi ES, Silverman NA. The blood supply of experimental liver metastases. I. The distribution of hepatic artery and portal vein blood to “small” and “large” tumours. Surgery. 1969;66:1067–1072
  13. Vente MAD, Hobbelink MGG, van het Schip AD, Zonnenberg BA, Nijsen JFW. Radionuclide liver cancer therapy: from concept to current clinical status. Anti-Cancer Agents in Med Chem. 2007;7:441–459
  14. Lambert B, Van de Wiele C. Treatment of hepatocellular carcinoma by means of radiopharmaceuticals. Eur J Nucl Med Mol Imaging. 2005;32:980–989
  15. Pillai MRA, Chakraborty S, Das T, Venkatesh M, Ramamoorthy N. Production logistics of 177Lu for radionuclide therapy. Appl Radiat Isot. 2003;59:109–118
  16. Ehrhardt GJ, Day DE. Therapeutic use of Y-90 microsphere. Int J Radiat Appl Instrum Part B Nucl Med Biol. 1987;14:233–242
  17. Lin M, Shon IH, Wilson R, D'Amours SK, Schlophoff G, Lin P. Treatment response in liver metastases following 90Y SIR-spheres: an evaluation with PET. Hepato-gastroenterol. 2007;54:910–912
  18. Mumper RJ, Ryo UY, Jay M. Neutron activated holmium-166-poly (l-lactic acid) microspheres: a potential agent for the internal radiation therapy of hepatic tumours. J Nucl Med. 1991;32:2139–2143
  19. Chinol M, Vallabhajosula S, Goldsmith SJ, Klein MJ, Deutsch KF, Chinen LK, et al. Chemistry and biological behaviour of samarium-153 and rhenium-186-labeled hydroxyapatite particles: potential radiopharmaceuticals for radiation synovectomy. J Nucl Med. 1993;34:1536–1542
  20. Unni PR, Chaudhari PR, Venkatesh M, Ramamoorthy N, Pillai MRA. Preparation and bioevaluation of 166Ho labeled hydroxyapatite (HA) particles for radiosynovectomy. Nucl Med Biol. 2002;29:199–209
  21. Clunie G, Lui D, Cullum I, Edwards JCW, Ell PJ. Samarium-153-particulate hydroxyapatite for radiation synovectomy: biodistribution data for chronic knee synovitis. J Nucl Med. 1995;36:51–57
  22. Chakraborty S, Das T, Banerjee S, Subramanian S, Sarma HD, Venkatesh M. 175Yb-labeled hydroxyapatite: a potential agent for use in radiation synovectomy of small joints. Nucl Med Biol. 2006;33:585–591
  23. Chakraborty S, Das T, Banerjee S, Sarma HD, Venkatesh M. Preparation and preliminary biological evaluation of 177Lu labeled hydroxyapatite as a promising agent for radiation synovectomy of small joints. Nucl Med Commun. 2006;27:661–668
  24. Solav SV, Unni PR, Chakraborty S, Chaudhari PR, Upadhayay I, Varghese E, et al. Preliminary report on the clinical evaluation studies of 166Ho-HA particles for radiation synovectomy. Ind J Nucl Med. 2000;15:132;[abstract]
  25. Kleinberg J. In: Inorganic synthesis. vol VII:New York: Tata McGraw Hill Book Co. Inc.; 1988;p. 63–64
  26. Awasthi V, Meinken G, Springer K, Srivastava SC, Freimuth P. Biodistribution of radioiodinated adenovirus fiber protein knob domain after intravenous injection in mice. J Virol. 2004;78:6431–6438
  27. Panagi Z, Beletsi A, Evangelatos G, Livaniou E, Jthakissos DS, Avagoustakis K. Effect of dose on the biodistribution and pharmacokinetics of PLGA and PLGA-mPEG nanoparticles. Int J Pharm. 2001;221:143–152
  28. Das T, Chakraborty S, Banerjee S, Sarma HD, Samuel G, Venkatesh M. 177Lu labeled metronidazole for possible use in targeting tumor hypoxia. Radiochim Acta. 2006;94:375–380
  29. Knapp FF, Callahan AP, Beets AL, Mirzadeh S, Hsieh BT. Processing of reactor-produced 188W for fabrication of clinical scale alumina-based 188W/188Re generators. Appl Radiat Isot. 1994;45:1123–1128
  30. Chakravarty R, Pandey U, Manolkar RB, Dash A, Venkatesh M, Pillai MRA. Development of an electrochemical 90Sr-90Y generator for separation of 90Y suitable for targeted therapy. Nucl Med Biol. 2008;35:245–253
  31. Raoul JL, Bourguet P, Bretangne JF, Duvauferrier R, Coornaert S, Darnault P, et al. Hepatic artery injection of I-131-labeled lipiodol. Part I. Biodistribution study results in patients with hepatocellular carcinoma and liver metastases. Radiology. 1988;168:541–545
  32. Lee YS, Jeong JM, Kim YJ, Chung JW, Park JH, Suh YG, et al. Synthesis of 188Re-labelled long chain alkyl diaminedithiol for therapy of liver cancer. Nucl Med Commun. 2002;23:237–242
  33. Paeng JC, Jeong JM, Yoon CJ, Lee YS, Suh YG, Chung JW, et al. Lipiodol solution of 188Re-HDD as a new therapeutic agent for transhepatic arterial embolization in liver cancer: preclinical study in a rabbit liver cancer model. J Nucl Med. 2003;44:2033–2038
  34. Andrews JC, Walker SC, Ackermann RJ, Cotton LA, Ensminger WB, Shapiro B. Hepatic radioembolization with yttrium-90 containing glass microspheres: preliminary results and clinical follow-up. J Nucl Med. 1994;35:1637–1644
  35. Turner JH, Claringbold PG, Klemp PFB, Cameron PJ, Martindal AA, Glancy RJ, et al. 166Ho-microsphere liver radiotherapy: a preclinical SPECT dosimetry study in the pig. Nucl Med Commun. 1994;15:545–553
  36. Conzone SD, Hafeli UO, Day DE, Ehrhardt GJ. Preparation and properties of rhenium glass microspheres intended for in-vivo radioembolization therapy. J Biomed Mater Res. 1998;42:617–625

PII: S0969-8051(08)00071-1

doi: 10.1016/j.nucmedbio.2008.03.003

Nuclear Medicine and Biology
Volume 35, Issue 5 , Pages 589-597 , July 2008

Article Tools

* Image Usage & Resolution